280 related articles for article (PubMed ID: 20215547)
21. Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway.
Thoennissen NH; O'Kelly J; Lu D; Iwanski GB; La DT; Abbassi S; Leiter A; Karlan B; Mehta R; Koeffler HP
Oncogene; 2010 Jan; 29(2):285-96. PubMed ID: 19855437
[TBL] [Abstract][Full Text] [Related]
22. CD24 enhances DNA damage-induced apoptosis by modulating NF-κB signaling in CD44-expressing breast cancer cells.
Ju JH; Jang K; Lee KM; Kim M; Kim J; Yi JY; Noh DY; Shin I
Carcinogenesis; 2011 Oct; 32(10):1474-83. PubMed ID: 21798852
[TBL] [Abstract][Full Text] [Related]
23. Effect of epidermal growth factor receptor tyrosine kinase inhibition on epithelial proliferation in normal and premalignant breast.
Chan KC; Knox WF; Gee JM; Morris J; Nicholson RI; Potten CS; Bundred NJ
Cancer Res; 2002 Jan; 62(1):122-8. PubMed ID: 11782368
[TBL] [Abstract][Full Text] [Related]
24. Dipyridamole prevents triple-negative breast-cancer progression.
Spano D; Marshall JC; Marino N; De Martino D; Romano A; Scoppettuolo MN; Bello AM; Di Dato V; Navas L; De Vita G; Medaglia C; Steeg PS; Zollo M
Clin Exp Metastasis; 2013 Jan; 30(1):47-68. PubMed ID: 22760522
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of the protein tyrosine phosphatase PRL-2 correlates with breast tumor formation and progression.
Hardy S; Wong NN; Muller WJ; Park M; Tremblay ML
Cancer Res; 2010 Nov; 70(21):8959-67. PubMed ID: 20841483
[TBL] [Abstract][Full Text] [Related]
26. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways.
Vanderlaag K; Su Y; Frankel AE; Grage H; Smith R; Khan S; Safe S
Breast Cancer Res Treat; 2008 May; 109(2):273-83. PubMed ID: 17624585
[TBL] [Abstract][Full Text] [Related]
27. Proapoptotic and antitumor activities of adenovirus-mediated p202 gene transfer.
Ding Y; Wen Y; Spohn B; Wang L; Xia W; Kwong KY; Shao R; Li Z; Hortobagyi GN; Hung MC; Yan DH
Clin Cancer Res; 2002 Oct; 8(10):3290-7. PubMed ID: 12374701
[TBL] [Abstract][Full Text] [Related]
28. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
Behera R; Kumar V; Lohite K; Karnik S; Kundu GC
Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637
[TBL] [Abstract][Full Text] [Related]
29. Anticancer effects of wogonin in both estrogen receptor-positive and -negative human breast cancer cell lines in vitro and in nude mice xenografts.
Chung H; Jung YM; Shin DH; Lee JY; Oh MY; Kim HJ; Jang KS; Jeon SJ; Son KH; Kong G
Int J Cancer; 2008 Feb; 122(4):816-22. PubMed ID: 17957784
[TBL] [Abstract][Full Text] [Related]
30. The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma.
Wu Y; Hooper AT; Zhong Z; Witte L; Bohlen P; Rafii S; Hicklin DJ
Int J Cancer; 2006 Oct; 119(7):1519-29. PubMed ID: 16671089
[TBL] [Abstract][Full Text] [Related]
31. Effects of miR-155 antisense oligonucleotide on breast carcinoma cell line MDA-MB-157 and implanted tumors.
Zheng SR; Guo GL; Zhai Q; Zou ZY; Zhang W
Asian Pac J Cancer Prev; 2013; 14(4):2361-6. PubMed ID: 23725141
[TBL] [Abstract][Full Text] [Related]
32. Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers.
Seitz S; Rick FG; Schally AV; Treszl A; Hohla F; Szalontay L; Zarandi M; Ortmann O; Engel JB; Buchholz S
Oncol Rep; 2013 Jul; 30(1):413-8. PubMed ID: 23624870
[TBL] [Abstract][Full Text] [Related]
33. Diosgenin targets Akt-mediated prosurvival signaling in human breast cancer cells.
Srinivasan S; Koduru S; Kumar R; Venguswamy G; Kyprianou N; Damodaran C
Int J Cancer; 2009 Aug; 125(4):961-7. PubMed ID: 19384950
[TBL] [Abstract][Full Text] [Related]
34. Eps8 regulates cellular proliferation and migration of breast cancer.
Chen C; Liang Z; Huang W; Li X; Zhou F; Hu X; Han M; Ding X; Xiang S
Int J Oncol; 2015 Jan; 46(1):205-14. PubMed ID: 25333707
[TBL] [Abstract][Full Text] [Related]
35. The PEA-15/PED protein regulates cellular survival and invasiveness in colorectal carcinomas.
Funke V; Lehmann-Koch J; Bickeböller M; Benner A; Tagscherer KE; Grund K; Pfeifer M; Herpel E; Schirmacher P; Chang-Claude J; Brenner H; Hoffmeister M; Roth W
Cancer Lett; 2013 Jul; 335(2):431-40. PubMed ID: 23481023
[TBL] [Abstract][Full Text] [Related]
36. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
[TBL] [Abstract][Full Text] [Related]
37. Rhein lysinate suppresses the growth of breast cancer cells and potentiates the inhibitory effect of Taxol in athymic mice.
Lin YJ; Zhen YS
Anticancer Drugs; 2009 Jan; 20(1):65-72. PubMed ID: 19343002
[TBL] [Abstract][Full Text] [Related]
38. The in vitro and in vivo effects of human umbilical cord mesenchymal stem cells on the growth of breast cancer cells.
Ma Y; Hao X; Zhang S; Zhang J
Breast Cancer Res Treat; 2012 Jun; 133(2):473-85. PubMed ID: 21947651
[TBL] [Abstract][Full Text] [Related]
39. Houttuyninum, an active constituent of Chinese herbal medicine, inhibits phosphorylation of HER2/neu receptor tyrosine kinase and the tumor growth of HER2/neu-overexpressing cancer cells.
Zhou NN; Tang J; Chen WD; Feng GK; Xie BF; Liu ZC; Yang D; Zhu XF
Life Sci; 2012 May; 90(19-20):770-5. PubMed ID: 22525372
[TBL] [Abstract][Full Text] [Related]
40. DNALK2 inhibits the proliferation and invasiveness of breast cancer MDA-MB-231 cells through the Smad-dependent pathway.
Wang K; Sun X; Feng HL; Fei C; Zhang Y
Oncol Rep; 2017 Feb; 37(2):879-886. PubMed ID: 28075462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]